Alok Gambhir, MD
Clinical Cardiac Electrophysiology · Gainesville, GANPI 1326208554
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (52.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by Abbott at 46.8% of the total. 2025 is the largest year on record at $34,214, 3.7 times the $9,126 reported in 2019. Among clinical cardiac electrophysiology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 635 payments — averaging $229.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$68K
- Boston Scientific$38K
- Biosense Webster, Inc.$18K
- Medtronic$8K
- Zywie, Inc.$6K
- Acutus Medical, Inc.$2K
- plus $6K from 31 others
Across 182 payments — averaging $8462.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$1.4M
- Biosense Webster, Inc.$72K
- Boston Scientific$60K
What the payments were for
- Consulting fees$76,21852%
- Speaking & faculty fees$11,2008%
- Travel & lodging$37,54726%
- Food & beverage$20,70114%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 204 | $68,243 |
| Boston Scientific | 127 | $37,859 |
| Biosense Webster, Inc. | 52 | $18,138 |
| Medtronic(2 entities) | 47 | $7,661 |
| Zywie, Inc. | 1 | $6,300 |
| Acutus Medical, Inc. | 13 | $1,811 |
| Cvrx, Inc. | 12 | $875 |
| Terumo Medical Corporation | 8 | $798 |
| Biotronik Inc. | 5 | $575 |
| Pfizer | 30 | $504 |
| E.r. Squibb & Sons, L.L.C. | 31 | $484 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 16 | $398 |
| Impulse Dynamics (USA) Inc. | 3 | $216 |
| Merck | 12 | $209 |
| Novartis | 8 | $196 |
| Kestra Medical Technology Services, Inc. | 6 | $178 |
| Johnson & Johnson | 10 | $166 |
| Cardiva Medical, Inc. | 8 | $144 |
| Elutia, Inc. | 5 | $132 |
| Amgen | 6 | $100 |
| Alnylam Pharmaceuticals Inc. | 4 | $93 |
| AstraZeneca | 6 | $91 |
| Portola Pharmaceuticals, LLC | 3 | $69 |
| Atricure, Inc. | 2 | $68 |
| Philips North America LLC | 3 | $60 |
| Angiodynamics, Inc. | 1 | $47 |
| Bardy Diagnostics, Inc. | 2 | $45 |
| Volta Medical Inc | 1 | $42 |
| Innovation Technologies Inc | 1 | $26 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Boehringer Ingelheim | 1 | $23 |
| Novo Nordisk | 1 | $18 |
| Bayer | 1 | $17 |
| Actelion Pharmaceuticals US, Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $16 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $14 |
| Altathera Pharmaceuticals LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMPLATZER AMULET$45,761
- WATCHMAN FLX$15,247
- Carto 3$11,492
- Watchman$10,729
- WATCHMAN Access System$8,828
- Accent Pacemaker$6,934
- Carto 3 System$5,792
- Carto Smarttouch$5,686
- CartoSound$5,686
- AVEIR$4,439
- Arctic Front$1,902
- JETi All In One Non-Sterile Kit$1,750
- Barostim Neo System$686
- ENSITE PRECISION$545
- VADO$350
- OPTIMIZER$334
- Acticor 7 VR-T DX$281
- Micra$256
- Confirm Rx$246
- Rivacor 7 DR-T$150
How this compares
$145,667 in reported general payments places this provider in the 90th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
See all clinical cardiac electrophysiology providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 437 | $446,982 |
| XareltoRivaroxaban | 88 | $100,840 |
| EntrestoSacubitril/Valsartan | 62 | $61,319 |
| FarxigaDapagliflozin Propanediol | 14 | $15,840 |
| Dofetilide | 47 | $13,229 |
| Amiodarone Hcl | 285 | $5,638 |
| Metoprolol Succinate | 348 | $4,716 |
| Flecainide Acetate | 102 | $4,460 |
| SotalolSotalol Hcl | 222 | $3,225 |
| Carvedilol | 179 | $1,910 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 52 | $1,703 |
| Pantoprazole Sodium | 88 | $1,325 |
| Atorvastatin Calcium | 124 | $1,131 |
| Olmesartan Medoxomil | 63 | $1,068 |
| Dilt-XrDiltiazem Hcl | 21 | $1,066 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $504 | $446,982437 claims |
| Johnson & JohnsonXarelto | $166 | $100,84088 claims |
| NovartisEntresto | $196 | $61,31962 claims |
| AstraZenecaFarxiga | $91 | $15,84014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
Other clinical cardiac electrophysiology in Gainesville
- Murtaza SundhuGainesville$59K
- Gautham KanagarajGainesville$28K
- Joshua LovelockGainesville$16K
- David DelurgioAtlanta$695K
- Thomas DeeringAtlanta$237K
- David NewtonSavannah$225K
- Michael LloydAtlanta$221K
- Kent NilssonAthens$198K
- Mikhael El-ChamiAtlanta$172K
- Sandeep GoyalAtlanta$153K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.